Document is current
Any future updates will be listed below
-
Authors
Delahaye, Jared L. https://orcid.org/0000-0002-6506-2208
You, Shihyun
Fu, Kai
Van Buren, Scott
Zhu, Cheng
Jordan, William
Ray, Avijit
Freudenberg, Johannes M.
Consalvo, Kristen M.
Pagliaroli, Luca
Joshi, Sohil
Dhawan, Puneet
Theodore, Dickens
Paff, Melanie
Walker, Jill
Singh, Jennifer M.
-
Funding
Funding for this research was provided by:
GSK (205695 [NCT02981602])
GSK (219239 [NCT06058390])
GSK (205873 [NCT06422767])
- License Information
-
More Information
Article History
Received: 18 March 2026
Accepted: 19 July 2026
First Online: 4 August 2026
Declarations
Conflict of interest: JL Delahaye, S You, K Fu, S Van Buren, C Zhu, W Jordan, A Ray, JM Freudenberg, KM Consalvo, L Pagliaroli, S Joshi, P Dhawan, D Theodore, M Paff, J Walker, and JM Singh, are employed by GSK and hold financial equities in GSK. JL Delahaye, D Theodore, and M Paff are also named inventors on pending patent applications related to bepirovirsen.
Ethical approval: The three trials informing these analyses were conducted in accordance with the Declaration of Helsinki, the Good Clinical Practice guidelines of the International Council for Harmonisation, and all applicable laws and regulations in participating countries.
Informed Consent: All participants provided written informed consent.
